Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

فلترة النتائج

Publisher : the association Format : Academic Journals Subject : multiple myeloma Subject : reverse transcriptase polymerase chain reaction Subject : terapia celular فلترة بواسطة : مؤلف

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.

Authors : Kurata K; Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Samur MK

Subjects: Transcription Factors*/Transcription Factors*/Transcription Factors*/genetics ; Transcription Factors*/Transcription Factors*/Transcription Factors*/metabolism ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/genetics

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 May 01; Vol. 29 (9), pp. 1807-1821.Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.

Authors : Sagawa M; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*genetics ; Neoplasm Proteins/Neoplasm Proteins/Neoplasm Proteins/*genetics

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Sep 01; Vol. 23 (17), pp. 5225-5237. Date of Electronic Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma.

Authors : Görgün G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. .; Samur MK

Subjects: Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*drug therapy ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*immunology ; Thalidomide/Thalidomide/Thalidomide/*analogs & derivatives

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Oct 15; Vol. 21 (20), pp. 4607-18. Date of Electronic Publication:Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي